# FDA 483 - Gautam T. Jayram, M.D. - January 23, 2026

Source: https://www.keypedia.com/records/483/gautam-t-jayram-md/d91168b9-372a-4af6-8057-c9778fab0cf8

> FDA 483 for Gautam T. Jayram, M.D. on January 23, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Gautam T. Jayram, M.D.
- Inspection Date: 2026-01-23
- Product Type: drugs
- Office Name: New Orleans District Office
- Summary: An FDA inspection of Urology Associates, Pc Research Department in Nashville, TN, revealed significant deficiencies in clinical investigation practices. The firm failed to maintain adequate and accurate case histories, did not conduct investigations in accordance with the investigational plan, and had inadequate investigational drug disposition records. These issues indicate serious concerns regarding data integrity and adherence to protocol requirements in clinical research.

## Related Officers

- [investigator](https://www.keypedia.com/people/gabrielle-j-swain/55f33430-41dc-4fae-bac0-ec6ea340feb6)

Company: https://www.keypedia.com/companies/gautam-t-jayram-md/d5d10ce1-b972-4840-bc0d-5ee2aadc2c10

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea